|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Cervical disc disorder with myelopathy, mid-cervical region
ICD-10 (CM) Code and Descriptor
|
M50.023 |
Cervical disc disorder at C6-C7 level with myelopathy
|
M50023 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 24.70%
|
22.33%
|
17.22%
|
14.55%
|
6.06%
|
6.00%
|
2.91%
|
2.20%
|
1.43%
|
0.71%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M50.023*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
A9270
|
NON-COVERED ITEM OR SERVICE |
345
|
1,056
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
239
|
1,179
|
|
97110
|
THERAPEUTIC EXERCISES |
233
|
436
|
|
97530
|
THERAPEUTIC ACTIVITIES |
200
|
307
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
184
|
1,690
|
|
J3010
|
FENTANYL CITRATE INJECTION |
176
|
399
|
|
C1713
|
ANCHOR/SCREW BN/BN,TIS/BN |
174
|
1,162
|
|
22551
|
ARTHRD ANT NTRBDY CERVICAL |
161
|
161
|
|
J2405
|
ONDANSETRON HCL INJECTION |
161
|
755
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
152
|
11,965
|
|
72040
|
X-RAY EXAM NECK SPINE 2-3 VW |
141
|
141
|
|
22853
|
INSJ BIOMECHANICAL DEVICE |
137
|
152
|
|
J1170
|
HYDROMORPHONE INJECTION |
131
|
277
|
|
72141
|
MRI NECK SPINE W/O DYE |
126
|
126
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
123
|
124
|
|
97116
|
GAIT TRAINING THERAPY |
111
|
134
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
108
|
262
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
107
|
233
|
|
J7120
|
RINGERS LACTATE INFUSION |
95
|
147
|
|
80048
|
METABOLIC PANEL TOTAL CA |
88
|
88
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M50.023 related to the following DRG Codes:
551-552
|
